This is a preview of subscription content, log in via an institution to check access.
Reference
Jagannath S, et al. Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the US Oncology and Therapy : 25 Oct 2021. Available from: URL: https://doi.org/10.1007/s40487-021-00175-z
Rights and permissions
About this article
Cite this article
Costs high after triple drug class therapy for multiple melanoma. PharmacoEcon Outcomes News 891, 6 (2021). https://doi.org/10.1007/s40274-021-08164-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08164-9